Use of Artificial Neural Networks in a QSAR Study of Anti-HIV Activity for a Large Group of HEPT Derivatives
暂无分享,去创建一个
[1] N. Pattabiraman,et al. All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach. , 1996, Journal of medicinal chemistry.
[2] Peter C. Jurs,et al. Descriptions of molecular shape applied in studies of structure/activity and structure/property relationships , 1987 .
[3] Raymond F. Schinazi,et al. Competitive inhibitors of human immunodeficiency virus reverse transcriptase , 1993 .
[4] Corwin Hansch,et al. QSAR of HIV inhibitors , 1992 .
[5] R T Walker,et al. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. , 1992, Journal of medicinal chemistry.
[6] S Shigeta,et al. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). , 1991, Journal of medicinal chemistry.
[7] Terry R. Stouch,et al. A simple method for the representation, quantification, and comparison of the volumes and shapes of chemical compounds , 1986, J. Chem. Inf. Comput. Sci..
[8] R T Walker,et al. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. , 1992, Journal of medicinal chemistry.
[9] A. D. Clark,et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] Erik De Clercq,et al. HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase , 1993, Medicinal research reviews.
[11] J L Meek,et al. Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies. , 1998, Journal of medicinal chemistry.
[12] R T Walker,et al. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. , 1989, Biochemical and biophysical research communications.
[13] Juan M. Luco,et al. QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives , 1997, J. Chem. Inf. Comput. Sci..
[14] R T Walker,et al. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. , 1989, Journal of medicinal chemistry.
[15] Supa Hannongbua,et al. Structure-activity correlation study of HIV-1 inhibitors: Electronic and molecular parameters , 1996, J. Comput. Aided Mol. Des..
[16] Richards Wg,et al. QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods. , 1993 .
[17] Supa Hannongbua,et al. Comparative Molecular Field Analysis of HIV‐1 Reverse Transcriptase Inhibitors in the Class of 1[(2‐Hydroxyethoxy)‐methyl]‐6‐(phenylthio)thymine , 1996 .
[18] S. V. Antonenko,et al. HIV-1 reverse transcriptase inhibitor design using artificial neural networks. , 1994, Journal of medicinal chemistry.
[19] C. Monneret,et al. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. , 1997, Journal of medicinal chemistry.